Einschlusskörper-Neufaltungsprozess Deutschland

• 

  Creating New Possibilities with Inclusion Body Refolding Technology

  This is really important as in the future this may help us create new medicines that can improve our lives. Yaohai is applying this technology to invent novel therapies against devastating diseases such as cancer and Alzheimer's. Cancer, a disease that struggles many people, and Alzheimer's, a debilitating disease of the memory. Correctly refolding proteins allows us to create better and less side effect prone medications that are much safer for humans to consume. 

  
  

• 

  The Power of Inclusion Body Refolding

  This allows us to produce drugs that address specific issues in our bodies by fixing those proteins. This is critical because everyone is unique, and a universal panacea can significantly assist numerous individuals in experiencing better well-being. 

  
  

• 

  A Key to Unlocking Biotech Innovations

  Inclusion body refolding can enable us to produce medicines that were previously difficult. For instance, certain cancer drugs must leave healthy cells alone and home in on exact proteins inside of cancer cells. This proteins are difficult to handle. Nonsense. We had learned to do inclusion body refolding, which made high-level production of these medicines possible. We can make many of these vital drugs, but not so we could just do it anyways, this new cool tech lets us. In order for more to people to have access to the treatment they need. 

  
  

Why choose Yaohai Inclusion Body Refolding Process?

• Robuste Lieferkette und Fertigungskapazitäten

  Yaohai Bio-Pharma, a top 10 Inclusion Body Refolding Process of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

• Fachkompetenz und langjährige Erfahrung

  Yaohai Bio-Pharma, a leader in Inclusion Body Refolding Process of microbial biologics, is located in Jiangsu. We are focusing on microbially produced therapeutics and vaccines that are suited for human, veterinary, and pet health management. We have modern RD as well as manufacturing technology platforms that cover the entire process, from engineering microbial strains, cell banking, process and method development, through to commercial and clinical manufacturing, making sure that we can ensure the successful supply of the most cutting-edge solutions. We have acquired a large amount of experience in the microbial bio processing field. More than 200 projects have been completed successfully and we support our clients in overcome regulations such as those of the US FDA and EU EMA. We also aid them with Australia TGA and China NMPA. We are able to respond rapidly to market requirements and offer customized CDMO services thanks to our experience and expertise.

• Qualitätssystem und Einhaltung globaler Vorschriften

  Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, Inclusion Body Refolding Process, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Anpassung, Effizienz und Kosteneffizienz

  Yaohai Bio-Pharma has experience in manufacturing biologics that are created from microorganisms. We offer bespoke RD solutions as well as manufacturing services while minimising potential risks. We have worked with diverse techniques, such as recombinant cellular subunits, vaccines (including peptides), growth factors, hormones, and the Inclusion Body Refolding Process. We are a specialist in many microorganisms like yeast extracellular and intracellular secretion (yields up to 15g/L) and bacteria intracellular soluble, and inclusion body (yields up to 10g/L). We have also developed a BSL-2 fermentation platform to create bacterial vaccines. We have a track record of improving production processes, thereby increasing yields and reducing costs. We have a highly-efficient technology team to ensure timely and high-quality delivery of projects. This helps us bring your products that are unique faster to the market.

Verwandte Produktkategorien

• Vorläufer-Insulin-Produktion als Einschlusskörper
• Einschlusskörper-Neufaltungsprozess
• Einschlusskörper-Solubilisierungsprozess

Finden Sie nicht, was Sie suchen?
Kontaktieren Sie unsere Berater für weitere verfügbare Produkte.